Production (Stage)
Acrivon Therapeutics, Inc.
ACRV
$1.17
$0.021.74%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 149.64M | 179.48M | 187.45M | 180.54M | 109.98M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.69M | 2.15M | 1.53M | 1.82M | 2.17M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 151.33M | 181.63M | 188.98M | 182.36M | 112.14M |
|
|
|||||
| Total Current Assets | 151.33M | 181.63M | 188.98M | 182.36M | 112.14M |
| Net Property, Plant & Equipment | 7.98M | 8.03M | 8.47M | 7.44M | 7.61M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.85M | 1.85M | 1.84M | 889.00K | 765.00K |
| Total Assets | 176.35M | 196.59M | 214.68M | 230.59M | 120.52M |
|
|
|||||
| Total Accounts Payable | 3.69M | 758.00K | 1.51M | 1.26M | 2.06M |
| Total Accrued Expenses | 8.40M | 15.40M | 12.27M | 8.76M | 5.90M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.11M | 1.06M | 1.04M | 978.00K | 944.00K |
| Total Finance Division Other Current Liabilities | 351.00K | -- | -- | 283.00K | 144.00K |
| Total Other Current Liabilities | 351.00K | -- | -- | 283.00K | 144.00K |
| Total Current Liabilities | 13.55M | 17.21M | 14.82M | 11.28M | 9.04M |
|
|
|||||
| Total Current Liabilities | 13.55M | 17.21M | 14.82M | 11.28M | 9.04M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 2.41M | 2.59M | 2.97M | 3.24M | 3.50M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 15.96M | 19.80M | 17.79M | 14.53M | 12.54M |
|
|
|||||
| Common Stock & APIC | 376.76M | 373.32M | 370.26M | 367.78M | 240.96M |
| Retained Earnings | -216.66M | -196.98M | -174.15M | -151.70M | -132.91M |
| Treasury Stock & Other | 283.00K | 447.00K | 782.00K | -19.00K | -70.00K |
| Total Common Equity | 160.39M | 176.79M | 196.89M | 216.06M | 107.98M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 160.39M | 176.79M | 196.89M | 216.06M | 107.98M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 160.39M | 176.79M | 196.89M | 216.06M | 107.98M |
|
|
|||||